Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Anti-diabetic effect of red quinoa polysaccharide on type 2 diabetic mellitus mice induced by streptozotocin and high-fat diet. β
Go to Publication β
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1308866 Pub: 2024 Epub: 2024 Feb 27 Authors Zang Y , Ge Y , Cao Y , Tang H , |
|
|
Quinoa alleviates osteoporosis in ovariectomized rats by regulating gut microbiota imbalance. β
Go to Publication β
Journal of the science of food and agriculture (J Sci Food Agric ) Vol: 104 Issue 9 Pages: 5052-5063 Pub: 2024 Jul Epub: 2024 Feb 15 Authors Dou J , Liang Z , Liu J , Liu N , Hu X , Tao S , Zhen X , Yang L , Zhang J , Jiang G , |
|
|
Saponins from Chenopodium quinoa Willd. husks alleviated high-fat-diet-induced hyperlipidemia via modulating the gut microbiota and multiple metabolic pathways. β
Go to Publication β
Journal of the science of food and agriculture (J Sci Food Agric ) Vol: 104 Issue 4 Pages: 2417-2428 Pub: 2024 Mar 15 Epub: 2023 Nov 30 Authors Yu Y , Ji X , Song L , Cao Y , Feng J , Zhang R , Tao F , Zhang F , Xue P , |
|
|
Quinoa Ameliorates Hepatic Steatosis, Oxidative Stress, Inflammation and Regulates the Gut Microbiota in Nonalcoholic Fatty Liver Disease Rats. β
Go to Publication β
Foods (Basel, Switzerland) (Foods ) Vol: 12 Issue 9 Pages: Pub: 2023 Apr 25 Epub: 2023 Apr 25 Authors Zhong L , Lyu W , Lin Z , Lu J , Geng Y , Song L , Zhang H , |
|
|
Quinoa Ameliorates Hepatic Steatosis, Oxidative Stress, Inflammation and Regulates the Gut Microbiota in Nonalcoholic Fatty Liver Disease Rats. β
Go to Publication β
Foods (Basel, Switzerland) (Foods ) Vol: 12 Issue 9 Pages: Pub: 2023 Apr 25 Epub: 2023 Apr 25 Authors Zhong L , Lyu W , Lin Z , Lu J , Geng Y , Song L , Zhang H , |
|
|
Total saponins from quinoa bran alleviate high-fat diet-induced obesity and systemic inflammation via regulation of gut microbiota in rats. β
Go to Publication β
Food science & nutrition (Food Sci Nutr ) Vol: 10 Issue 11 Pages: 3876-3889 Pub: 2022 Nov Epub: 2022 Jul 22 Authors Li W , Song Y , Cao YN , Zhang LL , Zhao G , Wu DT , Zou L , |
|
|
Quinoa bran soluble dietary fiber ameliorates dextran sodium sulfate induced ulcerative colitis in BALB/c mice by maintaining intestinal barrier function and modulating gut microbiota. β
Go to Publication β
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 216 Issue Pages: 75-85 Pub: 2022 Sep 1 Epub: 2022 Jul 2 Authors Liu J , Wang Z , Mai P , Hao Y , Wang Z , Wang J , |
|
|
Dietary quinoa (Chenopodium quinoa Willd.) polysaccharides ameliorate high-fat diet-induced hyperlipidemia and modulate gut microbiota. β
Go to Publication β
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 163 Issue Pages: 55-65 Pub: 2020 Nov 15 Epub: 2020 Jun 29 Authors Cao Y , Zou L , Li W , Song Y , Zhao G , Hu Y , |
|
|
Effects of Dietary Quinoa Seeds on Cecal Microorganisms and Muscle Fatty Acids of Female Luhua Chickens. β
Go to Publication β
Animals : an open access journal from MDPI (Animals (Basel) ) Vol: 12 Issue 23 Pages: Pub: 2022 Nov 28 Epub: 2022 Nov 28 Authors Wu T , Jiang X , Yang F , Wei Y , Zhao S , Jiao T , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
